The drug, called orforglipron and manufactured by Eli Lilly, is prescribed for type 2 diabetes and targets the same GLP-1 receptors as oral semaglutide. Like semaglutide, it lowers blood sugar levels, slows digestion and suppresses appetite. Unlike semaglutide tablets, it does not need to be taken on an empty stomach.
entry_p_bit = PE & ~VM
，推荐阅读服务器推荐获取更多信息
Екатерина Графская (Редактор отдела «Наука и техника»)
Anthropic rejects Pentagon’s AI demands